Product
ANXV
1 clinical trial
1 indication
Indication
Retinal Vein OcclusionClinical trial
Open-label, Dose Ascending Safety, Tolerability, and Proof of Concept Study to Evaluate the Use of ANXV (Human Recombinant Annexin A5) in the Treatment of Subjects With Recently Diagnosed Retinal Vein OcclusionStatus: Recruiting, Estimated PCD: 2024-06-01